L-689,560

L-689,560
Nazivi
	Preferisani IUPAC naziv 5,7-dihloro-4-(fenilkarbamoilamino)-1,2,3,4-tetrahidrohinolin-2-karboksilna kiselina
	Drugi nazivi 4-trans-2-karboksi-5,7-dihloro-4-fenilaminokarbonilamino-1,2,3,4-tetrahidrohinolin; L 689560; L-689,560; L-689560; trans-2-karboksi-5,7-dihloro-4-(((fenilamino)karbonil)amino)-1,2,3,4-tetrahidrohinolin;
Identifikacija
3D model (Jmol)	interaktivna slika;
PubChem C ID	4267713;
	SMILES C1C(C2=C(C=C(C=C2Cl)Cl)NC1C(=O)O)NC(=O)NC3=CC=CC=C3; ; ; ; ; ;
Svojstva
Hemijska formula	C17H15Cl2N3O3
Molarna masa	380,23 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

L-689,560 je antagonist NMDA receptora.^[3]

Reference

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Małgorzata Dybała; Dorota Maciag; Agnieszka Cichy; Lucyna Pomierny-Chamioło; Anna Partyka; Tadeusz Librowski; Gabriel Nowak (2006). „Medium supplementation with zinc enables detection of imipramine-induced adaptation in glycine/NMDA receptors labeled with [3H]L-689,560”. Pharmacol Rep. 58 (5): 753—7.